quinazolines has been researched along with Smoking Cessation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kittakoop, P; Mahidol, C; Ruchirawat, S | 1 |
| Miller, AA; Petty, WJ; Waller, LL | 1 |
2 review(s) available for quinazolines and Smoking Cessation
| Article | Year |
|---|---|
Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Antitubercular Agents; Humans; Isoxazoles; Molecular Structure; Pyridines; Quinazolines; Smoking Cessation | 2014 |
Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Liver; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Smoking; Smoking Cessation | 2010 |